Kaplan JE - Search Results

1

Current epidemiology of Pneumocystis pneumonia.

Morris A, Lundgren JD, Masur H, Walzer PD, Hanson DL, Frederick T, Huang L, Beard CB, Kaplan JE. Morris A, et al. Among authors: kaplan je. Emerg Infect Dis. 2004 Oct;10(10):1713-20. doi: 10.3201/eid1010.030985. Emerg Infect Dis. 2004. PMID: 15504255 Free PMC article. Review.

2

Current status of opportunistic infections in patients with HIV infection in the era of highly active antiretroviral therapy.

Masur H, Kaplan J. Masur H, et al. Curr Clin Top Infect Dis. 2001;21:64-82. Curr Clin Top Infect Dis. 2001. PMID: 11572162 Review. No abstract available.

3

Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996.

Jones JL, Hanson DL, Dworkin MS, Kaplan JE, Ward JW. Jones JL, et al. Among authors: kaplan je. J Infect Dis. 1998 Jul;178(1):114-20. doi: 10.1086/515593. J Infect Dis. 1998. PMID: 9652430

4

Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis.

Kaplan JE, Hanson DL, Navin TR, Jones JL. Kaplan JE, et al. J Infect Dis. 1998 Oct;178(4):1126-32. doi: 10.1086/515658. J Infect Dis. 1998. PMID: 9806044

5

Editorial response: do bacterial pneumonia and Pneumocystis carinii pneumonia accelerate progression of human immunodeficiency virus disease?

Kaplan JE, Janoff EN, Masur H. Kaplan JE, et al. Clin Infect Dis. 1999 Sep;29(3):544-6. doi: 10.1086/598630. Clin Infect Dis. 1999. PMID: 10530444 Review. No abstract available.

6

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.

Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, Holmberg S, Jones JL. Kaplan JE, et al. Clin Infect Dis. 2000 Apr;30 Suppl 1:S5-14. doi: 10.1086/313843. Clin Infect Dis. 2000. PMID: 10770911 Review.

7

Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4+ T lymphocyte counts above prophylaxis thresholds.

Dworkin MS, Hanson DL, Kaplan JE, Jones JL, Ward JW. Dworkin MS, et al. Among authors: kaplan je. J Infect Dis. 2000 Aug;182(2):611-5. doi: 10.1086/315734. Epub 2000 Jul 14. J Infect Dis. 2000. PMID: 10915098

8

Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States: 1994-2003.

Teshale EH, Hanson DL, Wolfe MI, Brooks JT, Kaplan JE, Bort Z, Sullivan PS; Adult and Adolescent Spectrum of HIV Disease Study Group. Teshale EH, et al. Among authors: kaplan je. Clin Infect Dis. 2007 Mar 15;44(6):879-83. doi: 10.1086/511862. Epub 2007 Feb 1. Clin Infect Dis. 2007. PMID: 17304464 No abstract available.

9

Does Pneumocystis carinii prophylaxis still need to be lifelong?

Masur H, Kaplan J. Masur H, et al. N Engl J Med. 1999 Apr 29;340(17):1356-8. doi: 10.1056/NEJM199904293401709. N Engl J Med. 1999. PMID: 10219072 No abstract available.

10

Introduction to the 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.

Masur H, Holmes KK, Kaplan JE. Masur H, et al. Among authors: kaplan je. Clin Infect Dis. 2000 Apr;30 Suppl 1:S1-4. doi: 10.1086/313847. Clin Infect Dis. 2000. PMID: 10770910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters